Luk, i would also agree, i was a little critical of the last...

Luk,
i would also agree, i was a little critical of the last results but they are achieved at very sub optimal xtoll blood levels (3% apparently) so they truely could be amazing.

i think it is hard for the market to view the results in the light that the pharmas will be viewing them.
- the drug has proven efficacy in earlier trials
- it continues to prove a 100% safety profile
- at very sub optimal doeses it still provides patient relief with NO SIDES
- it is cheap to manufacture

i would see no reason at all for this not to be licenced then to continue through FDA approval